Amylyx Pharmaceuticals Newsroom

Amylyx Pharmaceuticals: All of Shares Being Offered by Amylyx >AMLX

Dow JonesJan 10 08:39

Amylyx Pharmaceuticals: Funds for Commercialization and Pipeline Programs, Working Capital, General Corporate Purposes >AMLX

Dow JonesJan 10 08:39

Express News | Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

BreakingsJan 10 08:30

Express News | Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer

BreakingsJan 6 22:00

Why Is Amylyx Pharmaceuticals (AMLX) Among the Best Biotech Penny Stocks to Invest in Now?

Yahoo FinanceDec 31, 2024 03:52

Amylyx and Gubra Join Forces for Peptide Drug Discovery Collaboration

BenzingaDec 30, 2024 20:34

Investors Don't See Light At End Of Amylyx Pharmaceuticals, Inc.'s (NASDAQ:AMLX) Tunnel And Push Stock Down 26%

Simply Wall StDec 20, 2024 03:15

Selling Amylyx Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall StDec 11, 2024 20:03

BofA Securities Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Announces Target Price $10

Futu NewsDec 6, 2024 01:31 · Ratings

H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $12

Futu NewsDec 6, 2024 01:31 · Ratings

HC Wainwright & Co. Reiterates Buy on Amylyx Pharma, Maintains $12 Price Target

BenzingaDec 5, 2024 20:07 · Ratings

Express News | Amylyx Pharmaceuticals Shares up 1.7% on Late-Stage Trial Update for Low-Blood Sugar Drug

BreakingsDec 4, 2024 22:50

Express News | Amylyx Pharmaceuticals Inc - First Participant in Lucidity Trial Expected in Q1 2025

BreakingsDec 4, 2024 20:30

Amylyx Pharmaceuticals Announces Pivotal Phase 3 LUCIDITY Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

BusinesswireDec 4, 2024 20:30

Express News | Amylyx Pharmaceuticals Announces Pivotal Phase 3 Lucidity Trial Design for GLP-1 Receptor Antagonist (Avexitide) in Post-Bariatric Hypoglycemia

BreakingsDec 4, 2024 20:30

Amylyx Pharmaceuticals to Present at the 7th Annual Evercore ISI HealthCONx Conference

BusinesswireNov 27, 2024 22:00

Baird Upgrades Amylyx Pharmaceuticals(AMLX.US) to Buy Rating, Raises Target Price to $11

Futu NewsNov 19, 2024 16:36 · Ratings

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

BenzingaNov 18, 2024 22:59

This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

BenzingaNov 18, 2024 21:07

Amylyx Pharmaceuticals Raised to Outperform From Neutral by Baird

Dow JonesNov 18, 2024 20:36 · Ratings